Table 3.
Total WBC and lymphocyte counts in the peripheral blood of patients and healthy donors at various time points
| Baselinea | Month 2 | Month 6 | Month 12 | |
|---|---|---|---|---|
| RT group (n = 20) | ||||
| WBC | 5.7 ± 0.3 | 5.6 ± 0.4 | 5.7 ± 0.4 | 6.0 ± 0.4 |
| Lymphocyte | 1.7 ± 0.1 | 1.6 ± 0.1 | 2.0 ± 0.3 | 1.9 ± 0.1 |
| RT + CT group (n = 21) | ||||
| WBC | 4.3 ± 0.2 | 4.5 ± 0.1 | 5.0 ± 0.2 | 5.1 ± 0.3 |
| Lymphocyte | 1.1 ± 0.1 | 1.2 ± 0.1 | 1.4 ± 0.1 | 1.5 ± 0.1 |
| Healthy volunteers (n = 11) | ||||
| WBC | 6.9 ± 0.4 | 6.2 ± 0.5 | 6.6 ± 0.7 | ND |
| Lymphocyte | 2.0 ± 0.2 | 2.8 ± 0.7 | 2.6 ± 0.3 | ND |
Absolute number (×103) (mean ± SEM) of white blood cells and lymphocytes/μl in relation to time during long-term unmaintained follow-up of adjuvant radiotherapy (RT) or radio/chemotherapy (RT + CT) in patients with primary breast cancer
ND not done
WBC/lymphocyte in RT + CT group were significantly lower (P < 0.01) than the other groups by ANOVA test
aAfter end of adjuvant therapy